Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dave Byar's contribution to epidemiology

M H Gail1

  • 1Biostatistics Branch, National Cancer Institute, Rockville, Maryland 20892, USA.

Controlled Clinical Trials
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

This review highlights Dave Byar's contributions to epidemiology, focusing on his theoretical work. His advancements in statistical methods for case-control studies and risk estimation are detailed.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of α-tocopherol and β-carotene supplementation on liver cancer incidence and chronic liver disease mortality in the ATBC study.

British journal of cancer·2014
Same author

Fecal microbiota diversity in survivors of adolescent/young adult Hodgkin lymphoma: a study of twins.

British journal of cancer·2013
Same author

Two criteria for evaluating risk prediction models.

Biometrics·2010
Same author

Probability that a two-stage genome-wide association study will detect a disease-associated snp and implications for multistage designs.

Annals of human genetics·2008
Same author

Simple examples should not be extrapolated to the US population.

International journal of obesity (2005)·2008
Same author

Power and related statistical properties of conditional likelihood score tests for association studies in nuclear families with parental genotypes.

Annals of human genetics·2005
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

Area of Science:

  • Epidemiology
  • Biostatistics
  • Statistical Methods

Background:

  • Overview of Dave Byar's scientific career and approach.
  • Brief mention of his involvement in substantive epidemiologic projects.

Discussion:

  • Detailed review of theoretical contributions in epidemiology.
  • Exploration of extensions to the Mantel-Haenszel procedure.
  • Examination of other contingency table methods.

Key Insights:

  • Analysis of confounding in epidemiologic research.
  • Methods for estimating attributable and absolute risk.
  • Application of techniques to case-control data.

Outlook:

  • The enduring impact of Byar's statistical innovations.
  • Continued relevance of his work in risk estimation.
  • Foundation for future research in epidemiologic methods.